First Tracks Biotherapeutics Inc
TRAX | NASDAQ
$45.08
-$0.15 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$45.50
+$0.42 (+0.93%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Cash & Equivalents | 238.2M | 123.08M | 35.97M |
Short-Term Investments | 73.44M | 262.29M | 354.94M |
Long-Term Investments | n/a | 35.47M | 27.03M |
Other Long-Term Assets | 256K | 256K | 256K |
Receivables | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a |
Total Current Assets | 316.4M | 389.93M | 398.56M |
Property-Plant & Equipment | 13.89M | 16.23M | 18.27M |
Goodwill & Intangibles | n/a | n/a | n/a |
Total Long-Term Assets | 14.15M | 51.96M | 45.55M |
Total Assets | 330.55M | 441.89M | 444.11M |
Account Payables | 3.11M | 3.79M | 2.43M |
Deferred Revenue | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a |
Other Current Liabilities | n/a | 7.42M | 4.59M |
Total Current Liabilities | 31.02M | 36.18M | 18.22M |
Long-Term Debt | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a |
Total Long-Term Liabilities | 12.03M | 14.11M | 16.04M |
Total Liabilities | 43.06M | 50.3M | 34.26M |
Total Debt | 14.11M | 16.04M | 17.81M |
Book Value | 287.49M | 391.6M | 409.85M |
Book Value Per Share | 8.27 | 11.27 | 11.79 |
Common Stock | 287.51M | 391.29M | 410.65M |
Retained Earnings | n/a | n/a | n/a |
Comprehensive Income | -24K | 305K | -797K |
Shareholders Equity | 287.49M | 391.6M | 409.85M |
Total Investments | 73.44M | 297.76M | 381.97M |
Add to Watchlist
Select watchlists to add or remove TRAX